| Kirtine Lee Yang, MD | |
|
500 S Anaheim Hills Rd Ste 110, Anaheim, CA 92807 | |
| (714) 282-2229 | |
| (877) 794-9299 |
| Full Name | Kirtine Lee Yang |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 500 S Anaheim Hills Rd Ste 110, Anaheim, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033293915 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | A107592 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kirtine Lee Yang, MD 500 S Anaheim Hills Rd Ste 110, Anaheim, CA 92807-4762 Ph: (714) 282-2229 | Kirtine Lee Yang, MD 500 S Anaheim Hills Rd Ste 110, Anaheim, CA 92807 Ph: (714) 282-2229 |
News Archive
Solta Medical, Inc., a global leader in the medical aesthetics market, today announced that it has been included on the list of preliminary additions to the Russell 3000® Index and the Russell Global® Index posted by Russell Investments on June 11, 2010 on www.russell.com. These changes are expected to go into effect after the close of trading on Friday, June 25, 2010. All Russell indexes are subindexes of the Global Index.
After decades of overtreatment for low-risk prostate cancer and inadequate management of its more aggressive forms, patients are now more likely to receive medical care matched to level of risk, according to a study by researchers at UC San Francisco.
As society continues to navigate through the COVID-19 pandemic, there is a critical public health need to get ahead of the spread with a fast and simple testing for all.
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, today announced the completion of enrollment in a Phase 2a proof-of-concept trial for the treatment of impetigo.
Omega-3 fatty acids, combined with two blood-thinning drugs, significantly changed the blood-clotting process and may reduce the risk of heart attacks in patients with stents in their heart arteries, according to research reported in Arteriosclerosis, Thrombosis and Vascular Biology: Journal of the American Heart Association.
› Verified 4 days ago
Ritu Khurana Rawal, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 | |
Darren Murtari, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 | |
Jennifer Linzmeyer, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 714-279-4567 Fax: 714-278-5908 | |
Geman Cheng, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 | |
David J. Cordes, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 | |
Ya-mei T. Yu, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 |